Real Time Aging Testing for Medical Device Packaging

/
/
/
Real Time Aging Testing for Medical Device Packaging

60 second video overview

Typical response within 1 business day.

15-minute consult with a packaging specialist.

Real-time aging provides the actual shelf-life evidence required for sterile barrier validation. Unlike accelerated aging—which estimates long-term performance using elevated temperatures—real-time aging measures how a packaging system performs over the true passage of time under controlled room temperature conditions. 

Real-time aging is mandatory under ISO 11607 for verifying the shelf-life claims of terminally sterilized medical devices. It confirms that sterile barrier systems maintain integrity, material stability, and seal performance throughout the entire claimed shelf life. 

Q: Why is real-time aging mandatory under ISO 11607? 
A: ISO 11607 requires manufacturers to generate real-time data demonstrating that sterile barrier systems maintain integrity over the complete shelf-life duration. 

60 Second Video Overview

What Real-Time Aging Is and Why It Matters

Real-time aging evaluates how packaging materials, seals, and sterile barriers perform at normal storage temperatures over months or years. It provides: 

  • True, empirical shelf-life data 
  • Verification of accelerated aging assumptions 
  • Evidence required for regulatory submissions 
  • Long-term sterile barrier performance validation


Real-time aging is the foundation for demonstrating stability and durability of sterile packaging over its intended lifespan. 

Q: Does real-time aging provide the actual shelf-life data regulators want? 
A: Yes. Real-time aging is the only method that produces direct, time-based shelf-life evidence for sterile barrier systems. 

Environmental Conditions Used for Real-Time Aging (22–25°C)

Real-time aging must reflect real-world storage conditions. ISO 11607 requires manufacturers to maintain stable, controlled environments throughout the study. 

Typical conditions: 

  • Temperature: 20°C–25°C 
  • Most common range: 22°C–25°C 
  • Humidity: Ambient unless otherwise justified 
  • Lighting: Controlled, non-degrading exposure 
  • Monitoring: Continuous environmental logging with excursion alarms 


LSO’s real-time aging rooms are fully mapped, monitored, and designed to ensure reproducible stability conditions throughout multi-year studies.
 

Q: What temperature is used for real-time aging? 
A: Real-time aging is typically performed at 22–25°C, reflecting standard ambient storage conditions. 

LSO’s Real-Time Aging Capabilities (California Facility)

LSO conducts real-time aging exclusively in our California facility, equipped for long-term stability studies requiring strict environmental control and traceability. 

Facility Highlights 

  • Temperature-controlled rooms maintained between 22°C–25°C 
  • Full temperature mapping prior to study initiation 
  • Continuous environmental monitoring with excursion alarms 
  • Segregated shelving for study groups and time points 
  • Co-located sterile barrier integrity testing (no cross-facility transport) 
  • Long-term capacity for multi-year studies and multiple SKUs 

Q: Why does LSO conduct real-time aging in California only? 
A: Our California facility houses mapped, monitored rooms purpose-built for long-duration stability studies and co-located package integrity testing. 

Real-Time Aging vs Accelerated Aging: What’s the Difference?

Real-time aging and accelerated aging serve different—yet complementary—roles in shelf-life validation. 

Category Real-Time Aging Accelerated Aging (ASTM F1980)
Purpose Establishes actual shelf-life data Estimates shelf-life before real-time results exist
Temperature 20–25°C (typically 22–25°C) 50–60°C depending on material limits
Basis Measured passage of time Arrhenius equation (aging factor)
Regulatory Role Mandatory under ISO 11607 Supports initial shelf-life claims only
Testing Integrity tests at every time point Integrity testing after AA duration
Timeframe Months to years Weeks to months
When Used All sterile barrier claims Early validation + pre-launch justification
Relationship Confirms AA assumptions Provides early data before real-time completes

Q: Can accelerated aging replace real-time aging for shelf-life validation? 
A: No. Accelerated aging is useful early in development, but real-time aging is mandatory for confirming shelf-life claims. 

How Real-Time Aging Studies Are Planned and Executed

Because real-time aging cannot be compressed, study planning should begin early in the development cycle. 

A typical study includes: 

  1. Defining study duration (1, 2, 3+ years) 
  2. Selecting required time points (6, 12, 18, 24 months) 
  3. Allocating sterilized samples for each interval 
  4. Placing samples in controlled 22–25°C rooms 
  5. Pulling samples at each time point 
  6. Performing package integrity testing 
  7. Recording and reviewing results 
  8. Issuing a final real-time aging report 

Q: How early should real-time aging be started? 
A: As early as possible, because real-time duration cannot be shortened and is required for all final shelf-life claims. 

Real-Time Aging Workflow at LSO

LSO manages the full workflow to ensure data integrity and regulatory acceptance. 

Our Process 

  1. Study setup, chamber qualification, and sample intake 
  2. Continuous temperature monitoring with alerting 
  3. Scheduled time-point pulls 
  4. In-house sterile barrier integrity testing: 
  5. Data verification and documentation 
  6. Final reporting aligned with ISO 11607 requirements 

Q: What happens at each time point? 
A: Samples are removed from aging rooms and undergo required package integrity testing to verify sterile barrier performance over time. 

Why Medical Device Manufacturers Choose LSO

LSO provides: 

  • ISO 13485-certified facilities 
  • Validated aging and environmental chambers with continuous monitoring 
  • Accelerated turnaround 
  • Regulatory expertise for 510(k), PMA, and global submissions 
  • Complete documentation packages for audits and submissions

You reduce handoffs, shorten timelines, and receive shelf-life data with full regulatory alignment. 

Talk to a Medical Package Testing Specialist

If you’re planning a new shelf-life claim, updating your packaging system, or aligning your validation program with ISO 11607, LSO’s specialists can help design and execute real-time and accelerated aging studies with full in-house testing support. 

Frequently Asked Questions About Real-Time Aging

What is real-time aging?

Real-time aging involves storing sterile packaging at controlled ambient temperatures (22–25°C) for the full claimed shelf life to generate actual aging data. 

ISO 11607 requires real-time evidence to substantiate sterile barrier shelf-life claims. 

Exactly as long as the shelf-life claim. Real-time aging cannot be compressed. 

Testing occurs at each defined time point, commonly every 6–12 months. 

In our mapped, monitored California facility. 

No. Accelerated aging provides early estimates; real-time aging provides mandatory confirmation. 

60 second video overview

Typical response within 1 business day.

15-minute consult with a packaging specialist.

Sign up for email resources!

Receive the latest infographics, guides, and blog updates for medical device manufacturing, package testing, and sterilization.